Your Patient Needs Anakinra — Now What?

You've determined that Anakinra (Kineret) is the right treatment. Maybe it's for CAPS, DIRA, refractory Still's disease, acute gout that won't respond to standard therapies, or one of the other conditions where IL-1 blockade is clinically indicated. The clinical decision is made. Now comes the part that shouldn't be hard but often is: getting the drug into your patient's hands.

Anakinra's status as a single-source specialty biologic means that the path from prescription to patient involves more steps and more potential failure points than a standard oral medication. This guide provides a practical workflow to help your practice navigate those steps efficiently.

Current Availability: What You Need to Know

As of early 2026, Anakinra (Kineret) is not in shortage according to the FDA. Sobi (Swedish Orphan Biovitrum) continues to manufacture and distribute it through specialty pharmacy channels.

However, patients frequently report difficulty accessing Kineret. This is almost always due to one of three factors:

1. Retail pharmacy attempts: Patients try to fill at a standard pharmacy that doesn't stock biologics
2. Insurance delays: Prior authorization or step therapy holds up coverage
3. Refill timing: Patients wait too long to reorder and face gaps in specialty pharmacy processing

None of these are true shortages, but they feel like one to the patient who can't get their injection.

Why Patients Can't Find Anakinra at Their Regular Pharmacy

It's worth explaining to patients (and occasionally to staff) why Kineret doesn't work like picking up metformin or lisinopril:

• Cold chain storage: Kineret must be continuously refrigerated at 2°C-8°C (36°F-46°F). Most retail pharmacies don't maintain cold storage inventory for specialty biologics.
• Specialty distribution: Sobi distributes primarily through specialty pharmacy networks. Wholesale drug distributors that supply standard pharmacies may not carry it or may only stock it on a special-order basis.
• Single formulation: Kineret is available only as a 100 mg/0.67 mL prefilled syringe. There are no generics, biosimilars, vials, or alternative dosage forms.
• Low retail demand: Even large retail chains see too few Kineret prescriptions to justify keeping it in regular inventory.

5 Steps to Get Anakinra to Your Patient

Step 1: Route the Prescription to a Specialty Pharmacy

This is the single most impactful step. Do not send the prescription to a retail pharmacy and hope for the best. Instead:

• Use your practice's existing specialty pharmacy relationships
• Check with the patient's insurer for their preferred specialty pharmacy — using the in-network specialty pharmacy can streamline approval
• If unsure, contact Sobi's provider support at 866-547-0644 for specialty pharmacy referrals

Step 2: Initiate Prior Authorization Immediately

Don't wait for the specialty pharmacy to request it. Start the PA process at the same time you write the prescription — or even before.

• Most insurers require documentation of previous DMARD failure (for RA indication) or clinical diagnosis confirmation (for CAPS/DIRA)
• Have clinical notes, lab work, and relevant imaging ready to submit with the PA request
• Consider using electronic PA (ePA) if your practice management system supports it — this can reduce turnaround from weeks to days

Step 3: Enroll in Manufacturer Support Programs

Proactively enroll patients in the appropriate Sobi support program:

• Kineret QuickStart Program: Provides a temporary free supply for new patients experiencing insurance-related delays. This prevents the gap between prescription and coverage.
• Kineret Copay Assistance: For commercially insured patients — copay as low as $0/month, max $13,000/year in savings.
• Kineret Bridge Program: Free medication for commercially insured patients experiencing coverage delays or transitions.
• Sobi Patient Assistance Program: Free Kineret for eligible uninsured or underinsured patients.

All programs can be initiated through Sobi's support line: 866-547-0644 or via kineretrx.com.

Step 4: Check Pharmacy Stock with Medfinder

Medfinder for Providers allows your staff to quickly check which pharmacies have Anakinra available, reducing time spent on phone calls to distributors and pharmacies. This is especially useful when:

• The patient's usual specialty pharmacy is out of stock
• You need to identify an alternative pharmacy quickly
• A patient is transitioning between insurance plans or pharmacies

Step 5: Educate the Patient on Refill Management

Once the initial prescription is filled, the ongoing challenge is maintaining uninterrupted supply. Coach patients to:

• Reorder at least 7-10 days before running out
• Set a recurring calendar reminder for refill requests
• Keep the specialty pharmacy's contact number saved in their phone
• Know that PA renewals are needed periodically — your office should track these

When to Consider Alternatives

If access barriers are insurmountable despite the steps above, it may be clinically appropriate to consider alternative agents. The decision depends on the indication:

• CAPS/NOMID/DIRA: Canakinumab (Ilaris) — less frequent dosing (every 4-8 weeks) but significantly higher cost. Rilonacept (Arcalyst) — weekly dosing, approved for CAPS.
• Recurrent pericarditis: Rilonacept (Arcalyst) — FDA-approved specifically for this indication since 2021.
• RA: TNF inhibitors (adalimumab, etanercept, etc.) are more widely available and many have biosimilar options. Do not combine with anakinra.
• Acute gout: Colchicine, NSAIDs, or corticosteroids as first-line; anakinra remains an option when these are contraindicated.

For a complete alternatives overview: Alternatives to Anakinra if patients can't fill their prescription.

Workflow Tips for Your Practice

Integrating these steps into your standard workflow can prevent most Anakinra access issues:

• Create a biologic initiation checklist that includes specialty pharmacy routing, PA initiation, and manufacturer program enrollment as concurrent steps
• Designate a staff member (often a medical assistant or clinical coordinator) to manage specialty pharmacy communications and PA follow-up
• Track PA expiration dates in your EHR — set alerts 30 days before expiration to begin renewal
• Maintain a list of specialty pharmacies that handle Kineret in your area or that have delivered successfully for your patients
• Bookmark Medfinder for Providers for quick stock checks when standard channels are delayed

Additional Resources

• Anakinra shortage update for providers — Current supply status and clinical landscape
• How to help patients save money on Anakinra — Cost reduction strategies
• Anakinra drug interactions: What to avoid — Interaction reference
• Anakinra side effects — Patient-facing resource you can share

Final Thoughts

Anakinra access is a process problem, not a supply problem — at least in 2026. The medication exists, the manufacturer is producing it, and the specialty pharmacy infrastructure can deliver it. What breaks down is the workflow between prescription and delivery.

By routing to specialty pharmacies from the start, initiating PA early, enrolling in manufacturer programs proactively, and using tools like Medfinder, you can eliminate most of the friction your patients experience. The clinical decision to use Anakinra shouldn't be undermined by logistical failures.